ChatGPT is only so-so at letting physicians know if any given clinical study is relevant to their patient rosters and, as such, deserving of a full, time-consuming read. On the other hand ...
Imperfect algorithms. Resistant clinicians. Wary patients. Divisive disparities. The plot ingredients of a flashy techno-thriller coming to a cineplex near you? No—just a few of the many worries that provider organizations take on when they move to adopt AI at scale.
Fresh off an investment infusion of $25 million, a tech startup has launched an ambitious virtual consortium to seek “breakthrough medical discoveries and actionable findings” for the global battle against COVID-19.
The University of Pennsylvania is teaming with Intel to lead a federation of more than two dozen medical and research centers on an AI system for identifying brain tumors.
Researchers in the U.K. and U.S. have developed an automatic prediction model that can tell if someone is infected with COVID-19 based on symptoms alone.
A new scientific statement from the American Heart Association explores the many ways AI and machine learning are being used to improve care for heart patients.